Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: a retrospective cohort study (2023)

First Author: Evans A

Attributed to: Blood-brain barrier dysfunction and risk of dementia following blood-stream infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.01.24.23284916

Publication URI: http://dx.doi.org/10.1101/2023.01.24.23284916

Type: Preprint